CVE-2026-21103: GalaxyDiagnostics · Path Traversal
Source GCVE Database
Not known to be exploited · CVSS 6.8 Medium.
Data as of 27 Oct 2026, 05:11 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 15% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:P/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 9 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Samsung MobileSamsung Mobile Devices | Affected– | Fixed in– |
Description
Path traversal in GalaxyDiagnostics prior to SMR Sep-2026 Release 1 allows physical attackers to access files with system privilege.